Bernstein Liebhard LLP’s Post

FLA$HBACK!  In 2023, CohnReznick LLP advised on 675 deals across a broad span of specialties with 13% of those deals focused in the Healthcare Industry. Our Advisory Practice has a diverse group of leaders that specialize in Healthcare Performance Transformation, Transactions, and Valuations. Proud of our highly-skilled and well-prepared team! Looking forward to new collaborative transactional and transformational partnerships in 2024! #banking #bankingindustry #deals #dealmakers #duediligence #healthcare #hospitals #institutionalinvestors #innovation #investing #investingstrategies #investmentbanking #investmentopportunities #investmentstrategies #lenders #lowermiddlemarket #mergerandacquisitions #middlemarket #privateequity #strategicpartnerships #transactionadvisory #transactions #venturecapital

The M&A markets for healthcare companies are poised for significant upswing of activity in 2024. With the availability of abundant capital for transactions ($100billion+), strategic corporate and private equity are well positioned to compete for prominent, well-established and growing healthcare businesses. It is important not to go-it-alone in this market. An experienced advisory firm such as Paragon Ventures will ensure a competitive market for your business and provide surety to close through the process. Contact us at https://lnkd.in/e43RJKSd for a private, confidential discussion of the strategic options for your healthcare business. #mergersandacquisitions #healthcare #maximizevalue

The multibillion-dollar deals over the last year or so clearly demonstrate private equity’s appetite for the healthcare space. Financier Worldwide discusses private equity and M&A in the healthcare sector with Frank Aquila at Sullivan & Cromwell LLP. Read the full Q&A here: https://lnkd.in/eZXDv8ba #privateequity #mergersandacquisitions

🚨The Most-Read M&A Deal This Week: Goldman Sachs and Morgan Stanley Confirm Advisory on BD's $4.2bn Acquisition - Deal Summary Krugman Insights offers Reliable and Comprehensive Insights across M&A, Investment Banking, Private Equity, and Asset Management. 🔎 Financial Advisors on the Deal: Goldman Sachs, Morgan Stanley, Perella Weinberg, Citi 🔎 Legal Advisors on the Deal: Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates, Ropes & Gray LLP 🔎 Key Stakeholders: BD (Acquirer), Edwards Lifesciences' Critical Care Product Group (Target) 💡 BD has agreed to acquire Edwards Lifesciences’ Critical Care Product Group in a cash transaction valued at $4.2 billion. This acquisition will enhance BD’s portfolio with advanced patient monitoring technologies and AI-enabled clinical decision tools. The deal is projected to immediately benefit BD’s revenue growth, adjusted gross margin, adjusted operating margin, and adjusted EPS. BD expects to fund the transaction with $1 billion in cash and $3.2 billion in new debt. Post-transaction, BD aims to reduce its net leverage to 2.5x within 12 to 18 months using free cash flows for debt repayment. The transaction is expected to close by the end of 2024, pending customary regulatory reviews and closing conditions. ✅ FULL ARTICLE HERE: https://lnkd.in/e4U3kucK ✅ TRY 30 DAYS FREE: https://lnkd.in/eBHYx37M #GoldmanSachs #MorganStanley #BD #EdwardsLifesciences #MergersAndAcquisitions #InvestmentBanking #CorporateFinance #MedicalTechnology #StrategicPartnership #GlobalGrowth #FinancialAdvisory

𝐊𝐞𝐲 𝐀𝐬𝐩𝐞𝐜𝐭𝐬 𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐄𝐪𝐮𝐢𝐭𝐲 𝐅𝐢𝐫𝐦𝐬 𝐂𝐨𝐧𝐬𝐢𝐝𝐞𝐫 𝐢𝐧 𝐀𝐜𝐪𝐮𝐢𝐫𝐢𝐧𝐠 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐂𝐚𝐫𝐞 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬 With the primary care sector increasingly attracting private equity (PE) interest, understanding what these investors seek can help practice owners maximize their business’s value and appeal. Here are the critical factors that PE firms typically evaluate when considering acquisitions in the primary care space. 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞: https://lnkd.in/e2mTHjAJ . . . . . #PrimaryCare #PrivateEquity #MedicalPractice #HealthcareInvestment

𝐊𝐞𝐲 𝐀𝐬𝐩𝐞𝐜𝐭𝐬 𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐄𝐪𝐮𝐢𝐭𝐲 𝐅𝐢𝐫𝐦𝐬 𝐂𝐨𝐧𝐬𝐢𝐝𝐞𝐫 𝐢𝐧 𝐀𝐜𝐪𝐮𝐢𝐫𝐢𝐧𝐠 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐂𝐚𝐫𝐞 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬 With the primary care sector increasingly attracting private equity (PE) interest, understanding what these investors seek can help practice owners maximize their business’s value and appeal. Here are the critical factors that PE firms typically evaluate when considering acquisitions in the primary care space. 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞: https://lnkd.in/e2mTHjAJ . . . . . #PrimaryCare #PrivateEquity #MedicalPractice #HealthcareInvestment

Private equity is playing a transformative role in the healthcare M&A space, driving growth and consolidation across the sector. 💡 Discover how private equity is reshaping the healthcare landscape and what it means for the future. Watch the full video now! 🎥 🔗 : https://lnkd.in/efyqDzAk #PrivateEquity #HealthcareMergers #MergersAndAcquisitions #HealthcareIndustry #BusinessGrowth #HealthcareInvestments #MarketTrends

🎉 Announcing our latest closed deals! Each successful transaction signifies a significant milestone in our ongoing mission to drive value and foster growth within the healthcare sector. 🏥💼 We prioritize confidentiality above all else. While client names remain undisclosed, our unwavering commitment to discretion ensures your privacy throughout the process. Because of the time involved in majority of M&A deals, it is never too early to plan for an exit. For more information and receive a confidential valuation of your company please contact Dr. Allen Nazeri DDS MBA - allen@ahcteam.com #HealthcareMergers #ConfidentialityFirst #ExitStrategy #HealthcareIndustry #BusinessValuation #PrivateEquity #InvestmentBankers #MergersandAcquisitions #DentalGroups #HealthcareCompanies #HealthcareInvestments #MedicalSupply #PhysicalTherapy #Medicare #HomeHealth

Private credit will play a larger role in health care merger and acquisition activity and corporate financing decisions in 2024 and beyond. Find out more about this trend the winter 2024 edition of The Real Economy: Industry Outlook.

Private credit will play a larger role in health care merger and acquisition activity and corporate financing decisions in 2024 and beyond. Find out more about this trend the winter 2024 edition of The Real Economy: Industry Outlook.